A week-long course titled Assessing risks and benefits of treatments: methodological issues is a collection of advanced master classes taught by international experts in pharmacoepidemiology and comparative effectiveness research. Who should participate? PhD students, postdocs, clinicians, and other professionals seeking to advance their skills and knowledge. Basic to intermediate knowledge of epidemiology and biostatistics is assumed.